dr. M.C.J.M. (Miriam) Sturkenboom Associate Professor

Global Health

Contact

m.c.j.sturkenboom@umcutrecht.nl

Biography
Research Output

Biography

Miriam Sturkenboom is pharmacoepidemiologist and was professor in Observational Data Analysis at the department of Medical Informatics of the Erasmus University Medical Center in the Netherlands from 2008 until 2017. Mid 2017 she transferred to the department of Global Health at the Julius Center at University Medical Center Utrecht in the Netherlands. She has a PhD from the Faculty of Mathematics and Physics in Groningen (cum laude), a pharmacy degree from the same University and a Master in Epidemiology from the Harvard School of Public Health. She is president of the VACCINE.GRID charity that promotes global research into the effects of vaccines. She is past president of the International Society for Pharmacoepidemiology. She serves as expert to EMA, FDA, WHO and many other organizations

Her research interests focus on knowledge discovery from data collected in routine health care to improve evidence on drug and vaccine safety in particular in vulnerable populations (children, pregnancy and elderly). She established a research group at Erasmus MC that created national and most importantly international socio-technological infrastructures (e.g. Jerboa, Octopus) that allow for big data mining, pooling and analysis. These infrastructures have been tested and used as prototypes in many distributed networks in projects funded by the European Commission, the Innovative Medicines Initiative, the European Medicines Agency, ECDC, and also privately funded projects that she coordinate(d/s). She is coordinator of the ADVANCE public private collaboration, aiming to establish a tested system for the monitoring of benefits and risks of vaccines. In terms of quantitative research outputs: she supervises/d more than 50 PhD students, has more than 380 peer reviewed papers in the area of pharmacovigilance, pharmacoepidemiology and medical informatics and an h-index of 68.

Research Output

Choice of time period to identify confounders for propensity score matching, affected the estimate: a retrospective cohort study of drug effectiveness in asthmatic children

Osokogu Osemeke U., Khan Javeed, Nakato Swabra, Weibel Daniel, de Ridder Maria, Sturkenboom MCJM, Verhamme Katia 1 Sep 2018 In: Journal of Clinical Epidemiology. 101, p. 107-115.e3

Methodology for computing the burden of disease of adverse events following immunization

Mcdonald Scott A., Nijsten Danielle, Bollaerts Kaatje, Bauwens Jorgen, Praet Nicolas, van der Sande MAB, Bauchau Vincent, de Smedt Tom, Sturkenboom MCJM, Hahné Susan Jul 2018 In: Pharmacoepidemiology and Drug Safety. 27, p. 724-730

Impact of different assumptions on estimates of childhood diseases obtained from health care data: A retrospective cohort study

Osokogu Osemeke U, Pacurariu Alexandra, Mosseveld Mees, Rijnbeek Peter, Weibel Daniel, Verhamme Katia, Sturkenboom MCJM Jun 2018 In: Pharmacoepidemiology and Drug Safety. 27, p. 612-620 9 p.

Pharmacoepidemiology in pediatrics: Needs, challenges and future directions for research

Osokogu Osemeke U., Verhamme Katia, Sturkenboom MCJM, Kaguelidou Florentia Apr 2018 In: Therapie. 73, p. 151-156

Prenatal antidepressant exposure and the risk of attention-deficit hyperactivity disorder in children: A systematic review and meta-analysis

Man Kenneth K.C., Chan Esther W., Ip Patrick, Coghill David, Simonoff Emily, Chan Phyllis K.L., Lau Wallis C.Y., Schuemie Martijn J., Sturkenboom MCJM, Wong Ian C.K. 1 Mar 2018 In: Neuroscience & Biobehavioral Reviews. 86, p. 1-11 11 p.

Is patient exposure preapproval and postapproval a determinant of the timing and frequency of occurrence of safety issues?

Pacurariu Alexandra C., Hoeve Christina E., Arlett Peter, Genov Georgy, Slattery Jim, Sturkenboom MCJM, Straus Sabine M J M Feb 2018 In: Pharmacoepidemiology and Drug Safety. 27, p. 168-173 6 p.

Operational lessons learned in conducting a multi-country collaboration for vaccine safety signal verification and hypothesis testing: The global vaccine safety multi country collaboration initiative

Guillard-Maure Christine, Elango Varalakshmi, Black Steven, Perez-Vilar Silvia, Castro Jose Luis, Bravo-Alcántara Pamela, Molina-León Helvert Felipe, Weibel Daniel, Sturkenboom MCJM, Zuber Patrick L.F., 8 Jan 2018 In: Vaccine. 36, p. 355-362 8 p.

Building capacity for active surveillance of vaccine adverse events in the Americas: A hospital-based multi-country network

Bravo-Alcantara Pamela, Perez-Vilar Silvia, Molina-Leon Helvert Felipe, Sturkenboom MCJM, Black Steven, Zuber Patrick L. F., Maure Christine, Castro Jose Luis 8 Jan 2018 In: Vaccine. 36, p. 363-370 8 p.

Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination

Perez-Vilar Silvia, Weibel Daniel, Sturkenboom MCJM, Black Steven, Maure Christine, Castro Jose Luis, Bravo-Alcantara Pamela, Dodd CN, Romio Silvana A., de Ridder Maria, Nakato Swabra, Molina-Leon Helvert Felipe, Elango Varalakshmi, Zuber Patrick L. F. 8 Jan 2018 In: Vaccine. 36, p. 347-354 8 p.

Advancing collaborative vaccine benefits and safety research in Europe via the ADVANCE code of conduct

Sturkenboom MCJM 4 Jan 2018 In: Vaccine. 36, p. 194-195 2 p.

All Research Output (26)

Contact

Biography

Research Output

Deze website maakt gebruik van cookies